Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denma...
Q2 2026
Aug 14, 2026
Q1 2026
Mar 31, 2026
FY 2025
Dec 31, 2025
Q1 2025
Mar 31, 2025
FY 2024
Dec 31, 2024